R&D tax credits: take the payable credit now, or keep the loss?
Loss-making, R&D-intensive SMEs can surrender a loss for a 14.5% payable credit or keep it for later. What the rules say and how to weigh the choice.
A loss-making company that qualifies for enhanced R&D intensive support (ERIS) has a decision to make each year. It can surrender its loss for a cash credit now, or keep the loss to set against profits later. The cash is attractive, but the choice has a cost.
This article covers accounting periods beginning on or after 1 April 2024. For earlier periods the previous rules apply, and HMRC enquiries into those periods are still live.
Who has this choice?
Only a company claiming under ERIS. That means a small or medium-sized enterprise that makes a trading loss in the period (in HMRC's published view, measured before the additional deduction) and meets the R&D intensity condition: relevant R&D expenditure of at least 30% of total relevant expenditure, measured together with any connected companies. A company that met the condition and obtained relief in its most recent 12-month accounting period can also qualify.
What do you get if you surrender the loss?
ERIS works in two stages.
- An additional deduction. The company deducts a further 86% of its qualifying expenditure in calculating its trading result, which increases the loss.
- A payable credit. The company may then surrender all or part of its surrenderable loss for a credit of 14.5% of the amount surrendered.
The surrenderable loss is the lower of the unrelieved trading loss and 186% of the qualifying expenditure. The unrelieved loss is the trading loss reduced by any relief that was or could have been claimed against other profits of the same period, by any loss carried back and by any loss surrendered as group relief. The credit is also capped by reference to the company's PAYE and NIC: £20,000 plus three times its relevant PAYE and NIC liabilities for payment periods ending in the accounting period, unless an exemption from the cap applies.
HMRC's manual gives a simple example of a company that has no other income and is exempt from the cap. With £100,000 of qualifying expenditure and a trading loss of £50,000 before relief, it claims an additional deduction of £86,000. Its loss becomes £136,000. Surrendering all of it produces a credit of £19,720. Had the company had other profits in the period, the loss it could surrender would be reduced by the amount that could have been set against them, whether or not it made that claim.
The credit is not income of the company for tax purposes.
What do you give up?
The loss. The trading loss available to carry forward is reduced by the amount surrendered. A loss kept would be set against future profits and would save corporation tax at whatever rate the company then pays.
How should you weigh the two?
Compare 14.5p now for each £1 of loss surrendered with the rate at which that £1 would save tax later. If the later rate is higher, keeping the loss is worth more on paper. Three things then decide it.
- When profits will arrive. A saving that is several years away is worth less than cash today.
- How certain those profits are. A loss that is never used is worth nothing.
- What the cash would do now. For a company funding its own R&D, the credit may pay for the next stage of the work.
The company does not have to surrender the whole loss. It can surrender part and keep the rest.
Are there conditions on being paid?
Yes. A company cannot claim ERIS (the additional deduction, the pre-trading election or the payable credit) at a time when it is not a going concern, and a claim to the payable credit is treated as never made if the company stops being a going concern before the credit is paid. HMRC does not have to pay while the return is under enquiry, although it may make a provisional payment, and it does not have to pay if PAYE / NIC or VAT is outstanding. HMRC's stated aim is to pay 85% of payable credits within 40 days, or to contact the company within that time.
Could the company claim the merged scheme credit instead?
A company eligible for ERIS can choose the merged scheme R&D expenditure credit for the same expenditure, but not both. It is worth modelling as a third option.
Does the same choice arise under the merged scheme?
No. The merged scheme credit is 20% of qualifying expenditure and is treated as a taxable receipt of the trade. It is set against the company's corporation tax first and any balance is paid, subject to further steps. No loss is surrendered. The credit is, however, a taxable receipt of the trade, so it reduces the company's trading loss by the amount of the credit, and an amount equal to notional tax may be held back for use against later corporation tax.
Want help deciding?
We model both routes as part of preparing a claim. See our R&D tax relief page or contact us.